This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Suzuki, A. Articles by Esumi, H. Search for Related Content PubMed PubMed Citation Articles by Suzuki, A. Articles by Esumi, H.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2004, p. 3526-3535, Vol. 24, No. 8
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.8.3526-3535.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

ARK5 Is a Tumor Invasion-Associated Factor Downstream of Akt Signaling

Investigative Treatment Division, National Cancer Center Research Institute East, Kashiwa, Chiba 277-8577, Japan

Received 29 July 2003/ Returned for modification 29 August 2003/ Accepted 14 January 2004

AMP-activated protein kinases (AMPKs) are a class of serine/threonine protein kinases that are activated by an increase in intracellular AMP concentration. They are a sensitive indicator of cellular energy status and have been found to promote tumor cell survival during nutrient starvation. We recently identified a novel AMPK catalytic subunit family member, ARK5, whose activation is directly regulated by Akt, which, in turn, has been reported to be a key player in tumor malignancy. In this study, we attempted to determine whether ARK5 is involved in tumor malignancy under regulation by Akt. Matrigel invasion assays demonstrated that both overexpressed and endogenous ARK5 showed strong activity dependent on Akt. In addition, ARK5 expression induced activation of matrix metalloproteinase 2 (MMP-2) and MMP-9 following new expression of membrane type 1 MMP (MT1-MMP), and the MT1-MMP expression induced by ARK5 was initiated by rapamycin-sensitive signaling. In nude mice, ARK5 expression was associated with a significant increase in tumor growth and significant suppression of necrosis in tumor tissue. Interestingly, only the ARK5-overexpressing PANC-1 cell line (P/ARK) tumor showed invasion and metastasis in nude mice, although Akt was activated in tumors derived from both P/ARK and its parental cell line. We report that a novel AMPK catalytic subunit family member, ARK5, plays a key role in tumor malignancy downstream of Akt.

This article has been cited by other articles:

• Iiizumi, M., Bandyopadhyay, S., Pai, S. K., Watabe, M., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., Saito, K., Furuta, E., Liu, W., Xing, F., Okuda, H., Kobayashi, A., Watabe, K. (2008). RhoC Promotes Metastasis via Activation of the Pyk2 Pathway in Prostate Cancer. Cancer Res. 68: 7613-7620 [Abstract] [Full Text]  
• Laderoute, K. R., Amin, K., Calaoagan, J. M., Knapp, M., Le, T., Orduna, J., Foretz, M., Viollet, B. (2006). 5'-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments.. Mol. Cell. Biol. 26: 5336-5347 [Abstract] [Full Text]  
• Suzuki, A., Ogura, T., Esumi, H. (2006). NDR2 Acts as the Upstream Kinase of ARK5 during Insulin-like Growth Factor-1 Signaling. J. Biol. Chem. 281: 13915-13921 [Abstract] [Full Text]  
• Morito, N., Yoh, K., Fujioka, Y., Nakano, T., Shimohata, H., Hashimoto, Y., Yamada, A., Maeda, A., Matsuno, F., Hata, H., Suzuki, A., Imagawa, S., Mitsuya, H., Esumi, H., Koyama, A., Yamamoto, M., Mori, N., Takahashi, S. (2006). Overexpression of c-Maf Contributes to T-Cell Lymphoma in Both Mice and Human. Cancer Res. 66: 812-819 [Abstract] [Full Text]  
• Fisher, J. S., Ju, J.-S., Oppelt, P. J., Smith, J. L., Suzuki, A., Esumi, H. (2005). Muscle contractions, AICAR, and insulin cause phosphorylation of an AMPK-related kinase. Am. J. Physiol. Endocrinol. Metab. 289: E986-E992 [Abstract] [Full Text]  
• Gray, D., Jubb, A. M., Hogue, D., Dowd, P., Kljavin, N., Yi, S., Bai, W., Frantz, G., Zhang, Z., Koeppen, H., de Sauvage, F. J., Davis, D. P. (2005). Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers. Cancer Res. 65: 9751-9761 [Abstract] [Full Text]  
• Song, J. J., Lee, Y. J. (2005). Cross-talk between JIP3 and JIP1 during Glucose Deprivation: SEK1-JNK2 AND Akt1 ACT AS MEDIATORS. J. Biol. Chem. 280: 26845-26855 [Abstract] [Full Text]  
• Song, J. J., Lee, Y. J. (2005). Dissociation of Akt1 from its negative regulator JIP1 is mediated through the ASK1-MEK-JNK signal transduction pathway during metabolic oxidative stress: a negative feedback loop. J. Cell Biol. 170: 61-72 [Abstract] [Full Text]